Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H24O3S |
| Molecular Weight | 320.446 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC2=C(C=C1)C(=C(C=C2)C(C)(C)C)S(O)(=O)=O
InChI
InChIKey=WBEBQCINXJDZCX-UHFFFAOYSA-N
InChI=1S/C18H24O3S/c1-17(2,3)13-8-9-14-12(11-13)7-10-15(18(4,5)6)16(14)22(19,20)21/h7-11H,1-6H3,(H,19,20,21)
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/4390406
Sources: http://www.ncbi.nlm.nih.gov/pubmed/4390406
Dibunate (also known as Becantex, Becantyl, Linctussal, L-1633, and described as the 2,6-isomer or the 2,7-isomer) is an antitussive oral medication that was used in many counties all over the world. The current marketing status of the drug is unknown and is supposed to be "discontinued".
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
R05DB16
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
||
|
WHO-VATC |
QR05DB16
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZXY319VL5S
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
5285
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
DB13796
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
C171743
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
14992-58-6
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
145567
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
860
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
239-078-8
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
84746
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
402565
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | RxNorm | ||
|
DIBUNATE
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY | |||
|
DTXSID7048245
Created by
admin on Wed Apr 02 08:46:50 GMT 2025 , Edited by admin on Wed Apr 02 08:46:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)